For citations:

Metronomic therapy conducted through the vinorelbine/cyclophosphamide scheme significantly improves the overall survival in patients with rhabdomyosarcoma of the high-risk group stratified by the RMS-2005 protocol. Russian Journal of Pediatric Hematology and Oncology. 2018;5(3):107. (In Russ.)